Paper
22 May 1997 Er:YAG laser-induced changes in skin in vivo and transdermal drug delivery
Stephen Thomas Flock, Tom Stern, Paul Lehman, Scott Dinehart M.D., Tom Franz, George Liu, Scott J. Stern M.D.
Author Affiliations +
Abstract
It has been shown that laser ablation of stratum corneum, in vitro, can result in an increased uptake of topically applied pharmaceuticals. We have performed measurements of drug permeation, using an in vitro model of human skin, that involves a portable Er:YAG laser used to ablate the stratum corneum. For the first time, this method of drug administration was tested in vivo in human volunteers, whereby a hydrocortisone blanching assay was used to assess the efficiency of the procedure. The results show that this is a safe and efficient way to ablate stratum corneum for the purpose of enhanced transcutaneous drug administration.
© (1997) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Stephen Thomas Flock, Tom Stern, Paul Lehman, Scott Dinehart M.D., Tom Franz, George Liu, and Scott J. Stern M.D. "Er:YAG laser-induced changes in skin in vivo and transdermal drug delivery", Proc. SPIE 2970, Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems VII, (22 May 1997); https://doi.org/10.1117/12.275068
Lens.org Logo
CITATIONS
Cited by 3 scholarly publications and 1 patent.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Skin

Er:YAG lasers

Laser ablation

In vivo imaging

In vitro testing

Diffusion

Calibration

RELATED CONTENT


Back to Top